tradingkey.logo

Allurion Technologies Inc

ALUR
1.405USD
-0.095-6.33%
收盘 12/19, 16:00美东报价延迟15分钟
10.91M总市值
亏损市盈率 TTM

Allurion Technologies Inc

1.405
-0.095-6.33%

关于 Allurion Technologies Inc 公司

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Allurion Technologies Inc简介

公司代码ALUR
公司名称Allurion Technologies Inc
上市日期Mar 29, 2021
CEOGaur (Shantanu)
员工数量134
证券类型Ordinary Share
年结日Mar 29
公司地址11 Huron Dr Ste 200
城市NATICK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编01760
电话15086474000
网址https://www.allurion.com/en
公司代码ALUR
上市日期Mar 29, 2021
CEOGaur (Shantanu)

Allurion Technologies Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-20.50%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+100.00%
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Mr. Ojas A. Buch
Mr. Ojas A. Buch
Chief Operating Officer
Chief Operating Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-20.50%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+100.00%
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
All other countries
1.88M
55.73%
Spain
786.00K
23.26%
Italy
436.00K
12.90%
France
274.00K
8.11%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月27日 周四
更新时间: 11月27日 周四
持股股东
股东类型
持股股东
持股股东
占比
RTW Investments L.P.
63.60%
Leavitt Equity Partners III LP
5.00%
Armistice Capital LLC
2.00%
Romulus Capital Management, LLC
1.76%
Compute Health Sponsor LLC
1.41%
其他
26.23%
持股股东
持股股东
占比
RTW Investments L.P.
63.60%
Leavitt Equity Partners III LP
5.00%
Armistice Capital LLC
2.00%
Romulus Capital Management, LLC
1.76%
Compute Health Sponsor LLC
1.41%
其他
26.23%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
64.19%
Corporation
6.41%
Investment Advisor
2.23%
Hedge Fund
2.16%
Individual Investor
2.03%
Venture Capital
1.89%
其他
21.09%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
68
6.53M
39.03%
+3.35M
2025Q3
70
3.18M
46.56%
+1.57K
2025Q2
85
3.18M
48.45%
-269.85K
2025Q1
86
1.95M
28.76%
+237.16K
2024Q4
84
752.22K
40.38%
-48.13K
2024Q3
168
830.35K
127.59%
-73.34K
2024Q2
179
581.38K
156.78%
+113.95K
2024Q1
186
467.42K
172.37%
-2.84M
2023Q4
188
468.03K
181.14%
+55.07K
2023Q3
189
413.41K
181.62%
-47.54K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
RTW Investments L.P.
2.54M
32.75%
--
--
Jun 30, 2025
Leavitt Equity Partners III LP
462.76K
5.96%
+296.10K
+177.66%
Feb 19, 2025
Armistice Capital LLC
185.00K
2.38%
-206.64K
-52.76%
Jun 30, 2025
Romulus Capital Management, LLC
163.14K
2.1%
--
--
Mar 14, 2025
Compute Health Sponsor LLC
130.51K
1.68%
-1.00
-0.00%
Mar 14, 2025
Gupta (Krishna K.)
73.06K
0.94%
--
--
Mar 14, 2025
Gaur (Shantanu)
78.03K
1.01%
+8.00K
+11.42%
May 19, 2025
UBS Financial Services, Inc.
62.21K
0.8%
-19.94K
-24.27%
Jun 30, 2025
The Vanguard Group, Inc.
49.37K
0.64%
--
--
Jun 30, 2025
Olayan Investments Company Establishment
49.70K
0.64%
--
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
Janus Henderson Small Cap Growth Alpha ETF
0%
iShares Micro-Cap ETF
占比0%
Janus Henderson Small Cap Growth Alpha ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
公告日期
类型
比率
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1

常见问题

Allurion Technologies Inc的前五大股东是谁?

Allurion Technologies Inc 的前五大股东如下:
RTW Investments L.P.持有股份:2.54M,占总股份比例:32.75%。
Leavitt Equity Partners III LP持有股份:462.76K,占总股份比例:5.96%。
Armistice Capital LLC持有股份:185.00K,占总股份比例:2.38%。
Romulus Capital Management, LLC持有股份:163.14K,占总股份比例:2.10%。
Compute Health Sponsor LLC持有股份:130.51K,占总股份比例:1.68%。

Allurion Technologies Inc的前三大股东类型是什么?

Allurion Technologies Inc 的前三大股东类型分别是:
RTW Investments L.P.
Leavitt Equity Partners III LP
Armistice Capital LLC

有多少机构持有Allurion Technologies Inc(ALUR)的股份?

截至2025Q4,共有68家机构持有Allurion Technologies Inc的股份,合计持有的股份价值约为6.53M,占公司总股份的39.03%。与2025Q3相比,机构持股有所增加,增幅为-7.53%。

哪个业务部门对Allurion Technologies Inc的收入贡献最大?

在FY2025Q2,--业务部门对Allurion Technologies Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI